DAR No 1: Evenity®. Romosozumab for osteoporosis

Content tools

Share it

DAR No 1: Evenity®. Romosozumab for osteoporosis
DAR No 2: Forxiga® / Edistride®. Dapagliflozin in chronic kidney disease
DAR No 3: Verquvo®. Vericiguat in heart failure
DAR No 4: Jardiance®. Empagliflozin for symptomatic, chronic heart failure

Heart attacks in exchange for fractures. Does it worth?

Download pdf

It is hard to find a profile of patients candidates to romosozumab because of the doubtful clinical relevance of the effects observed in fracture reduction and the safety concerns.

Enviar comentario

You can send us a comment or suggestion and we will respond to most frequently asked questions

Competing interests (complete this field only if you have competing interests)

First name, middle initial and last name *

Email *

Current position or occupation *

Place of work *

Suggestions/Comments *

navarra.es

DAR No 1: Evenity®. Romosozumab for osteoporosis

Heart attacks in exchange for fractures. Does it worth?